155 related articles for article (PubMed ID: 34234555)
41. Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer.
Li J; Wang D; Zhang C
Front Oncol; 2023; 13():1232192. PubMed ID: 38260829
[TBL] [Abstract][Full Text] [Related]
42. Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients.
Cai J; Yang F; Chen X; Huang H; Miao B
Pharmgenomics Pers Med; 2021; 14():797-811. PubMed ID: 34285549
[TBL] [Abstract][Full Text] [Related]
43. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
[TBL] [Abstract][Full Text] [Related]
44. An aberrant DNA methylation signature for predicting the prognosis of head and neck squamous cell carcinoma.
Chen D; Wang M; Guo Y; Wu W; Ji X; Dou X; Tang H; Zong Z; Zhang X; Xiong D
Cancer Med; 2021 Sep; 10(17):5936-5947. PubMed ID: 34313009
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
[TBL] [Abstract][Full Text] [Related]
46. Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
Lin J; Cao Z; Yu D; Cai W
Front Genet; 2021; 12():709133. PubMed ID: 34603375
[TBL] [Abstract][Full Text] [Related]
47. Identification of the Pyroptosis-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.
Luo B; Lin J; Cai W; Wang M
Front Genet; 2021; 12():771847. PubMed ID: 34938319
[TBL] [Abstract][Full Text] [Related]
48. Identification of a nine-gene prognostic signature for gastric carcinoma using integrated bioinformatics analyses.
Wu KZ; Xu XH; Zhan CP; Li J; Jiang JL
World J Gastrointest Oncol; 2020 Sep; 12(9):975-991. PubMed ID: 33005292
[TBL] [Abstract][Full Text] [Related]
49. A five-gene methylation signature predicts overall survival of patients with clear cell renal cell carcinoma.
Jing X; Xu G; Gong Y; Li J; LingfengWu ; Zhu W; He Y; Li Z; Pan S
J Clin Lab Anal; 2021 Dec; 35(12):e24031. PubMed ID: 34716619
[TBL] [Abstract][Full Text] [Related]
50. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
51. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
[TBL] [Abstract][Full Text] [Related]
52. A Risk Score Model Based on Nine Differentially Methylated mRNAs for Predicting Prognosis of Patients with Clear Cell Renal Cell Carcinoma.
Zhou J; Liu G; Wu X; Zhou Z; Li J; Ji Z
Dis Markers; 2021; 2021():8863799. PubMed ID: 33510822
[TBL] [Abstract][Full Text] [Related]
53. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
[No Abstract] [Full Text] [Related]
54. Screening of miRNAs as Prognostic Biomarkers for Colon Adenocarcinoma and Biological Function Analysis of Their Target Genes.
Zheng G; Zhang G; Zhao Y; Zheng Z
Front Oncol; 2021; 11():560136. PubMed ID: 33816220
[TBL] [Abstract][Full Text] [Related]
55. A novel ferroptosis-related genes model for prognosis prediction of lung adenocarcinoma.
Li F; Ge D; Sun SL
BMC Pulm Med; 2021 Jul; 21(1):229. PubMed ID: 34256754
[TBL] [Abstract][Full Text] [Related]
56. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
[TBL] [Abstract][Full Text] [Related]
57. In silico development and clinical validation of novel 8 gene signature based on lipid metabolism related genes in colon adenocarcinoma.
Jiang C; Liu Y; Wen S; Xu C; Gu L
Pharmacol Res; 2021 Jul; 169():105644. PubMed ID: 33940186
[TBL] [Abstract][Full Text] [Related]
58. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
59. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
[TBL] [Abstract][Full Text] [Related]
60. Genome-wide analysis to identify a novel distant metastasis-related gene signature predicting survival in patients with gastric cancer.
Hu BL; Xie MZ; Li KZ; Li JL; Gui YC; Xu JW
Biomed Pharmacother; 2019 Sep; 117():109159. PubMed ID: 31247467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]